RNTX - Rein Therapeutics, Inc.

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Dec 31, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
EPS Growth YoY (%)	64.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	24.0% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	44.5% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	22.2% Good → Good Stable Year-over-year change in earnings per share Optimal: > 10%	37.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	70.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-40.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	32.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-15.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	18.1% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	-57.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	71.4% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	77.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	82.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	-46.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-6.1% Weak ↓ Weak Declining Year-over-year change in net income	-6.1% Weak ↓ Weak Declining Year-over-year change in net income	22.0% Good → Good Stable Year-over-year change in net income	22.7% Good ↑ Good Improving Year-over-year change in net income	22.7% Good ↑ Good Improving Year-over-year change in net income	22.7% Good ↑ Good Improving Year-over-year change in net income	-458.4% Weak ↓ Weak Declining Year-over-year change in net income	-48.8% Weak ↑ Weak Improving Year-over-year change in net income	-48.8% Weak ↓ Weak Declining Year-over-year change in net income	-48.8% Weak ↓ Weak Declining Year-over-year change in net income	-61.4% Weak ↓ Weak Declining Year-over-year change in net income	43.3% Excellent ↑ Excellent Improving Year-over-year change in net income	43.3% Excellent ↑ Excellent Improving Year-over-year change in net income	43.3% Excellent ↑ Excellent Improving Year-over-year change in net income	33.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-20.7% Weak → Weak Stable Year-over-year change in net income	-20.7% Weak ↓ Weak Declining Year-over-year change in net income	-20.7% Weak ↓ Weak Declining Year-over-year change in net income	—	-3.4% Weak → Weak Stable Year-over-year change in net income	-3.4% Weak ↓ Weak Declining Year-over-year change in net income	-3.4% Weak ↓ Weak Declining Year-over-year change in net income	—	6.4% Fair ↑ Fair Improving Year-over-year change in net income	6.4% Fair ↑ Fair Improving Year-over-year change in net income	6.4% Fair ↓ Fair Declining Year-over-year change in net income	-2.9% Weak ↓ Weak Declining Year-over-year change in net income	3.0% Caution ↓ Caution Declining Year-over-year change in net income	24.0% Good ↑ Good Improving Year-over-year change in net income	4.9% Caution ↑ Caution Improving Year-over-year change in net income	-2.5% Weak ↑ Weak Improving Year-over-year change in net income	-18.8% Weak ↑ Weak Improving Year-over-year change in net income	-92.8% Weak ↓ Weak Declining Year-over-year change in net income	-66.5% Weak ↓ Weak Declining Year-over-year change in net income	-54.5% Weak ↓ Weak Declining Year-over-year change in net income	-48.2% Weak Weak Year-over-year change in net income	11.0% Fair Fair Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	60.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	55.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	38.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	4.3% Caution Caution Year-over-year change in free cash flow	-47.8% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Dec 31, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
FCF / Net Income (x)	1.48x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	—	1.12x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.12x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.42x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.06x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.22x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Dec 31, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
Return on Invested Capital (%)	-8.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-35.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-152.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-62.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	-5.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-55.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-45.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	3.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-9.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-135.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-68.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-21.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-20.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-14.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-10.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-20.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-10.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	-50.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-436%)	-189.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1360%)	-11.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-11.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-11.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-75.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-602%)	—	—	—	-7.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-42.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-385%)	-37.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-349%)	-33.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-323%)	-24.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	-37.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-347%)	-29.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-296%)	-23.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-255%)	-15.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-203%)	-13.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-12.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-11.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	—	-54.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-461%)	-40.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-370%)	-69.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-561%)	-45.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-401%)	-31.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-311%)	-24.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-260%)	-56.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-474%)	-35.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-339%)	-28.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-290%)	-28.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-293%)	-18.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-223%)	-14.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	-11.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-177%)	4.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-73%)	—	4.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-74%)	—	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Dec 31, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
Net Debt (USD)	$-8.54M	$-4.45M	$-3.21M	$-4.05M	$-5.72M	$-7.43M	$-12.87M	$-17.65M	$-21.92M	$-12.04M	$-17.31M	$-12.07M	$-13.17M	$-7.78M	$-5.19M	—	—	$-7.45M	$-3.60M	—	—	$-19.28M	$-7.05M	$-7.85M	$-17.12M	$-10.70M	$-5.31M	$-6.87M	$-10.16M	$-11.27M	$-10.63M	$-7.72M	$-11.98M	$-6.78M	$-11.86M	$-13.43M	$-9.40M	—	$-20.71M	$-4.50M	$-3.88M	$-3.77M	$-6.21M

📊 What does each share earn? 8 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Dec 31, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	—	—	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.10	$-0.19	$-1.22	$-0.21	$-0.28	$-0.25	$-2.20	$-0.27	$-0.45	$-0.86	$-1.57	$-0.40	$-0.39	$-1.05	$-1.00	$-1.40	$-1.76	—	$-5.67	$-1.40	$-1.20	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.13	$-0.11	—	$-0.13	—	$-0.28	—	—	—	$-0.63	—	—	—	$-1.03	—	$-1.54	$-1.25	—	—	$-1.60	$-0.85	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Dividend per Share (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	$0.00	$0.00	—	—	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	—	—	$0.00	$0.00	—	—	—
Book Value per Share (USD)	$0.64	$0.41	$0.61	$1.84	$2.08	$2.27	$2.51	—	—	—	$20.12	$2.47	$2.82	$3.14	$4.10	$5.00	$6.30	$7.95	$9.69	$11.07	$12.41	$13.62	$5.55	$6.25	$8.48	$7.03	$11.54	$16.41	$22.45	$17.27	$26.58	$35.33	$44.60	$55.62	$64.92	$73.39	$-5.36K	—	$-5.17K	—	—	—	—
Tangible Book Value per Share (USD)	$0.41	$-0.29	$-0.11	$-0.09	$-0.02	$0.06	$0.27	—	—	—	$2.61	$2.47	$2.82	$3.14	$4.10	$5.00	$6.30	$7.95	$9.69	$11.07	$12.41	$13.62	$5.55	$6.25	$8.48	$7.03	$11.54	$16.41	$22.45	$17.27	$26.58	$35.33	$44.60	$55.62	$64.92	$73.39	$-5.36K	—	$-5.17K	—	—	—	—
Basic Weighted Avg Shares (shares)	67.08M	30.35M	—	26.36M	24.19M	21.92M	—	21.66M	19.91M	8.30M	—	4.54M	4.54M	4.54M	—	4.54M	4.54M	—	—	4.53M	4.52M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Dividend Payout Ratio (%)	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	—	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Dec 31, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
Working Capital (USD)	$31.74M	$-8.18M	$-1.85M	$-570.00K	$-1.09M	$2.35M	$7.91M	$13.03M	$18.22M	$8.23M	$13.88M	$11.17M	$12.76M	$14.22M	$18.49M	—	—	$35.85M	$43.67M	—	—	$61.25M	$12.37M	$10.72M	$14.74M	$7.54M	$13.71M	$20.07M	$27.17M	$9.77M	$16.41M	$22.95M	$30.84M	$39.59M	$46.95M	$53.09M	$6.52M	—	$17.00M	—	—	—	—
Total Equity (USD)	$55.20M	$11.59M	$16.92M	$46.19M	$48.01M	$49.88M	$54.39M	—	—	—	$98.30M	$11.20M	$12.79M	$14.27M	$18.62M	$22.70M	$28.62M	$36.11M	$43.90M	$50.11M	$56.13M	$61.42M	$12.16M	$12.46M	$16.65M	$9.77M	$16.05M	$22.82M	$29.98M	$12.85M	$19.60M	$26.03M	$32.87M	$40.98M	$47.80M	$54.01M	$-120.78M	—	$-111.81M	—	—	$-94.32M	$-82.04M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Dec 31, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—
Depreciation Expense (USD)	—	—	$0.00	$0.00	—	$0.00	$0.00	—	—	$59.00K	$52.00K	$12.00K	$12.00K	$43.00K	$43.00K	$43.00K	$42.00K	$41.00K	$40.00K	$39.00K	$40.00K	$2.00K	$10.00K	—	—	$70.00K	$75.00K	—	—	$31.00K	$49.00K	—	—	$46.00K	$44.00K	—	—	$22.00K	$42.00K	$58.00K	—	—	—
Net Income, GAAP (USD)	$-5.84M	$-5.84M	$-31.97M	$-5.50M	$-5.50M	$-5.50M	$-40.98M	$-7.11M	$-7.11M	$-7.11M	$-7.34M	$-4.78M	$-4.78M	$-4.78M	$-4.55M	$-8.42M	$-8.42M	$-8.42M	$-6.80M	$-6.97M	$-6.97M	$-6.97M	—	$-6.75M	$-6.75M	$-6.75M	$-7.24M	$-7.21M	$-7.21M	$-7.21M	$-7.03M	$-7.43M	$-9.49M	$-7.59M	$-6.87M	$-6.26M	$-4.92M	$-4.56M	$-4.44M	$-4.22M	$-5.53M	—	—
Operating Cash Flow (USD)	$-8.64M	$-3.42M	$-3.22M	$-3.55M	—	$-6.17M	$-4.81M	—	—	$-5.27M	$-10.39M	—	—	$-4.66M	$-4.41M	$-6.97M	$-5.68M	$-7.80M	$-6.25M	$-7.26M	$-3.76M	$-6.48M	$-4.69M	—	—	$-5.67M	$-6.30M	—	—	$-7.50M	$-6.66M	—	—	—	$-5.84M	—	—	—	—	—	—	—	—

Rein Therapeutics, Inc.

Analytical Summary

43-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare RNTX with peers